HOME >> BIOLOGY >> NEWS
Improved predictions of warming-induced extinctions sought

In the March 2007 issue of BioScience, an international team of 19 researchers calls for better forecasting of the effects of global warming on extinction rates. The researchers, led by Daniel B. Botkin, note that although current mathematical models indicate that many species could be at risk from global warming, surprisingly few species became extinct during the past 2.5 million years, a period encompassing several ice ages. They suggest that this "Quaternary conundrum" arises because the models fail to take adequate account of the mechanisms by which species persist in adverse conditions. Consequently, the researchers "believe that current projections of extinction rates are overestimates." A critical review of the four types of model now in common use leads the team to identify various simplifying assumptions in the models that can lead to biases.

The authors make eight recommendations for improving forecasts of extinction rates under global warming. The recommendations cover a wide range, from clarifying the definition of biodiversity to improving existing models and developing better ones. They include, for example, the suggestion that current models need to be more rigorously tested, that explanations of extinction other than climate change need to be more thoroughly considered, and that better data should be brought to bear on the problem, especially information from the fossil record of Quaternary ice ages. The authors acknowledge, however, that they do not fully understand why so many species persisted during these ice ages, and caution that some genetic research suggests that species might in fact be more vulnerable than the fossil record indicates.


'"/>

Contact: Samantha Katz
skatz@aibs.org
202-628-1500
American Institute of Biological Sciences
1-Mar-2007


Page: 1

Related biology news :

1. Improved NIST SRM aids lead poisoning detection
2. Improved imaging for identifying breast cancer in overweight women
3. Improved speech without vocal cords
4. Improved blood safety measures from Pall can increase platelet availability
5. Improved statistical tools reveal many linked loci
6. Improved process of drying lumber may save millions
7. Improved cancer treatments aim of new biology research program
8. Improved recipe for magnetic brain stimulation
9. Improved molecular switch could serve as sensor, medical tool
10. Nitrogen study may improve ecological predictions
11. Monitoring data confirm key predictions about extinction

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Improved predictions warming induced extinctions sought

(Date:6/16/2015)... , June 16, 2015 /CNW Telbec/ - handyem ... centralized around the incorporation of handyem,s HPC-150 portable ... laboratory, the Mo-POD™. This unprecedented model of mobile ... Conference at the Pennsylvania ... June 15 th to 18 th ...
(Date:6/16/2015)... , June 16, 2015 Fingerprint Cards ... fingerprint sensors in the company,s portfolio from one of its ... planned to mainly take place during the third quarter 2015. ... Asia . Jörgen Lantto, CEO of ...   the   growing interest from smartphone OEMs in integrating ...
(Date:6/15/2015)... June 16, 2015 According to ... by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, ... 2020" published by MarketsandMarkets, The Natural Language Processing Market ... CAGR of 18.4% for the forecast period 2015-2020. ... 46 F igures spread   through 155 P ...
Breaking Biology News(10 mins):handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3FPC Receives Order for Touch Fingerprint Sensors of 375 MSEK 2Natural Language Processing Market Worth $13.4 Billion by 2020 2Natural Language Processing Market Worth $13.4 Billion by 2020 3Natural Language Processing Market Worth $13.4 Billion by 2020 4Natural Language Processing Market Worth $13.4 Billion by 2020 5
(Date:7/2/2015)... ... July 02, 2015 , ... In’Tech ... surgical instruments in Orthopedics, announced today the acquisition of Turner Medical, Inc ... provider of surgical instruments to the Spine Industry. The acquisition of Turner Medical ...
(Date:7/1/2015)... , July 1, 2015   Decision ... frequently cited advantages of Otezla are its oral ... profile, as reported by surveyed rheumatologists. Otezla was ... for the treatment of active psoriatic arthritis in ... current standard of care includes conventional oral treatments ...
(Date:7/1/2015)... ALTO, Calif. , July 1, 2015 /PRNewswire/ ... focused on the development of groundbreaking drugs to ... (ALS), announced today that Robert G. Miller ... Center at Sutter Health,s California Pacific Medical Center ... The ALS Association for $1.5 million to help ...
(Date:7/1/2015)... ... July 01, 2015 , ... A newly launched business plan ... lower the barriers to innovation in life sciences R&D. The Pistoia Alliance President’s Startup ... prizes of US$15,000 and a period of expert mentorship from a senior industry figure ...
Breaking Biology Technology:In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3
Cached News: